Investor · 2 deals

Forbion

Disclosed deals

Every published round Forbion took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.

Company	Stage	Announced	Amount	Role	Alongside	Sources
Inflazome	Unnamed stage	17 Dec 2018	$63m	Lead	Longitude Capital Novartis Fountain Healthcare Partners	SmartCompany (Mon 17 Dec 2018), SmartCompany (Tue 4 Dec 2018)
Pheon Therapeutics	Series A	28 Sep 2022	$68m	Lead	Brandon Capital Atlas Venture	Brandon Capital portfolio, Brandon Capital portfolio

Portfolio

Companies Forbion has backed in a published round, and companies whose existing shares it bought off another holder.

Company	What it does	First invested	Rounds	Led
Inflazome		17 Dec 2018	1	1
Pheon Therapeutics		28 Sep 2022, Series A	1	1

Funds

Fund closes reported for Forbion, as distinct from the investments it has made.

Fund	Announced	Committed	Target	Close	Sources
No fund closes recorded for Forbion yet.

Portfolio companies acquired

Companies Forbion has backed that another company then bought. An exit for the holding, not a deal Forbion did.

Company	Bought by	Kind	Announced	Price
No portfolio company of Forbion is recorded as having been acquired.

Something wrong? Tell us

Forbion

Disclosed deals

Portfolio

Funds

Portfolio companies acquired

People

Coverage

Brandon Capital news

Queensland biotech startup Inflazome raises $63 million to change the way we treat Alzheimer’s